Medicine and Dentistry
Patient
100%
Takayasu's Arteritis
94%
Rituximab
47%
Cyclophosphamide
46%
Prednisolone
40%
Granulomatosis with Polyangiitis
40%
Tocilizumab
38%
Biological Product
34%
Aortitis
29%
Eosinophilic
29%
Dermatomyositis
29%
Syndrome
29%
Hemiplegia
29%
Inpatient
29%
Hand-Schüller-Christian Disease
29%
Immunoglobulin A Nephropathy
26%
Pregnancy
25%
Immunosuppressive Treatment
24%
Colitis
23%
Enteritis
22%
Vasculitis
22%
Polymyositis
21%
Corticosteroid
20%
Combination Therapy
18%
Woman
18%
Symptom
18%
Myositis
16%
Cerebral Hemorrhage
16%
Man
16%
Association
15%
Methotrexate
15%
B Cell
15%
Rheumatoid Arthritis
14%
Myeloperoxidase
14%
Transient Ischemic Attack
14%
Neurologic Disease
14%
Relapse
14%
Diseases
14%
Therapeutic Procedure
13%
Adverse Event
13%
Granulocyte Colony Stimulating Factor
13%
Autoantibody
12%
Spontaneous Remission
12%
Targeted Therapy
12%
T Cell
11%
Drug
11%
Chemotherapeutic Agent
11%
Anti-Neutrophil Cytoplasmic Antibody
11%
Electroencephalogram
11%
Drug Megadose
11%
Pharmacology, Toxicology and Pharmaceutical Science
Aortic Arch Syndrome
35%
Cyclophosphamide
29%
Aortitis
29%
Dermatomyositis
29%
Tocilizumab
29%
Biological Product
28%
Prednisolone
23%
Colitis
23%
Enteritis
22%
Polymyositis
21%
Myositis
16%
Corticosteroid
16%
Rheumatoid Arthritis
14%
Adverse Event
13%
Granulocyte Colony Stimulating Factor
13%
Autoantibody
12%
Drug
11%
Survival
9%
Interstitial Pneumonia
8%
Melanoma
8%
Antibody
8%
Wegener Granulomatosis
7%
Case Report
7%
Pegfilgrastim
6%
Methotrexate
5%
Retrospective Study
5%
Artery Lesion
5%
Ascending Colon
5%
Relapse
5%
Maintenance Dose
5%
Immunology and Microbiology
Arteritis
38%
Rituximab
33%
Prednisolone
29%
Cyclophosphamide
29%
Dermatomyositis
29%
Pregnancy
25%
Enteritis
22%
Polymyositis
21%
Biological Product
20%
Dose
18%
Myositis
16%
Autoantibodies
12%
B Cell
11%
Monoclonal Antibodies
11%
Co-Stimulation
11%
Vasculitis
9%
Association
8%
Gene
8%
Differentiation
8%
Monospecific Antibody
8%
Granulomatosis with Polyangiitis
7%
Tocilizumab
5%
Methotrexate
5%
Vasculitis
5%
Etanercept
5%
Infliximab
5%
Autoimmunity
5%
Interleukin-6 Receptor
5%
Abatacept
5%
Electric Potential
5%
Aorta
5%
CD20
5%
TNF Inhibitor
5%
Maintenance Drug Dose
5%